M.J. Osborn, et al. TALEN-based Gene Correction for Epidermolysis Bullosa. Molecular Therapy. 2013 April 2. doi:10.1038/mt.2013.56.

Aug

28

Editas Medicine to Participate in Upcoming Investor Conferences

Aug

7

Editas Medicine Announces Second Quarter 2024 Results and Business Updates

Jul

31

Editas Medicine Announces Second Quarter 2024 Results Conference Call and Corporate Update